Controlled release of CPT-11 and shRNA from graphene oxide-entrapped thermo-sensitive chitosan hydrogel for glioma treatment

Controlled release of CPT-11 and shRNA from graphene oxide-entrapped thermo-sensitive chitosan hydrogel for glioma treatment

碩士 === 長庚大學 === 化工與材料工程學系 === 105

Bibliographic Details
Main Authors:	Wan Ting Lu, 呂宛庭
Other Authors:	J. P. Chen
Format:	Others
Language:	zh-TW
Published:	2017
Online Access:	http://ndltd.ncl.edu.tw/handle/z85t9a

Similar Items

Injectable Thermo-Sensitive Chitosan Hydrogel Containing CPT-11-Loaded EGFR-Targeted Graphene Oxide and SLP2 shRNA for Localized Drug/Gene Delivery in Glioblastoma Therapy
by: Yu-Jen Lu, et al.
Published: (2020-09-01)

Dual targeted delivery of CPT11 and SLP2 shRNA to cancer cells by magnetic graphene oxide for glioma treatment
by: Yu Lun Weng, et al.
Published: (2019)

New NGR-targeted shRNA-loaded Liposome Suppresses Glioma Growth
by: ZHAO Guanjian, et al.
Published: (2019-08-01)

Optimized PCR conditions and increased shRNA fold representation improve reproducibility of pooled shRNA screens.
by: Žaklina Strezoska, et al.
Published: (2012-01-01)

Monitoring on truncation of AMCase treated with shRNA
by: WANG,YUNG-HSIANG, et al.
Published: (2016)

Design of vector for the expression of shRNA in transgenic animals
by: Sawafta, Ashraf
Published: (2008)

Controlled release of doxorubicin from folate-conjugated graphene oxide in thermo-sensitive hydrogel
by: Yi Teng Fong, et al.
Published: (2014)

Genome-wide shRNA screen in YT cells for induction of T-bet- regulated markers
by: Wei-Ting Huang, et al.
Published: (2014)

Design and cloning strategies for constructing shRNA expression vectors
by: McIntyre Glen J, et al.
Published: (2006-01-01)

Suppression of cancer progression by MGAT1 shRNA knockdown.
by: Reza Beheshti Zavareh, et al.
Published: (2012-01-01)

Energy profile and secondary structure impact shRNA efficacy
by: Zeng Xiao, et al.
Published: (2009-07-01)

Using shRNA experiments to validate gene regulatory networks
by: Catharina Olsen, et al.
Published: (2015-06-01)

Optimization of duplex stability and terminal asymmetry for shRNA design.
by: Olga V Matveeva, et al.
Published: (2010-01-01)

Silencing Human Rb2/p130 with shRNA
by: Eleonora Leucci, et al.
Published: (2007-01-01)

Improved siRNA/shRNA functionality by mismatched duplex.
by: Haoquan Wu, et al.
Published: (2011-01-01)

Development of Thrombospondin 1 shRNA as anti-cancer agent
by: Tzu-YangWeng, et al.
Published: (2014)

Optimization of Duplex Stability and Terminal Asymmetry for shRNA Design
by: Spiridonov, Alexey Nikolaevich, et al.
Published: (2010)

Efficient shRNA-Mediated Inhibition of Gene Expression in Zebrafish
by: Sive, Hazel L., et al.
Published: (2012)

Flow Cytometry Detection of Bacterial Cell Entrapment within the Chitosan Hydrogel and Antibacterial Property of Extracted Chitosan
by: Nafise Sadat Majidi, et al.
Published: (2016-10-01)

Flow Cytometry Detection of Bacterial Cell Entrapment within the Chitosan Hydrogel and Antibacterial Property of Extracted Chitosan
by: Nafise Sadat Majidi, et al.
Published: (2016-09-01)

Growth inhibition of glioma cells (SVGA) by anti-SV40 LT shRNA delivered by the JC virus-like particle
by: Yufu Huang, et al.
Published: (2013)

Study on Properties of Chitosan Thermo- sensitive Hydrogel with Different Glycerophosphate
by: Yu-Ru Chen, et al.
Published: (2012)

Validation of shRNA clones for gene silencing in 293FT cells
by: Wang, Wen
Published: (2008)

Functional selection of shRNA loops from randomized retroviral libraries.
by: Stig Mølgaard Rask Jensen, et al.
Published: (2012-01-01)

Criteria for effective design, construction, and gene knockdown by shRNA vectors
by: Lich John D, et al.
Published: (2006-01-01)

PCR-based generation of shRNA libraries from cDNAs
by: Chan Wing C, et al.
Published: (2006-06-01)

Delivery of therapeutic AGT shRNA by PEG-Bu for hypertension therapy.
by: Yu-Qiang Wang, et al.
Published: (2013-01-01)

ShRNA-targeted COMMD7 suppresses hepatocellular carcinoma growth.
by: Lu Zheng, et al.
Published: (2012-01-01)

Synthetic lethal and shRNA screen in oral cancer cell lines
by: Meng-Yi Lin, et al.
Published: (2008)

The novel approach for cancer therapy:by skin delivery of IDO shRNA
by: Meng-Chi Yen, et al.
Published: (2009)

Construction shRNA of IL17RA and Expression of Band 3
by: Hung-Chen Yeh, et al.
Published: (2015)

Treatment of Indoleamine 2,3-dioxygenase shRNA Has Therapeutic Efficacy in an Orthotopic Hepatoma Model
by: Tzu-Ting Huang, et al.
Published: (2009)

Artemether combined with shRNA interference of vascular cell adhesion molecule-1 significantly inhibited the malignant biological behavior of human glioma cells.
by: Ying-Bin Wang, et al.
Published: (2013-01-01)

An analysis of the prognostic and predictive roles of PPARα and PPARy in gliobastoma and the effects of shRNA-mediated PPARα knockdown in glioma stem cells
by: Haynes, Harry Russell
Published: (2017)

Effect of shRNA Survivin-mediated Inhibition of Proliferation in A549 Cells
by: Lihong WU, et al.
Published: (2011-12-01)

RNAi mechanisms in Huntington’s disease therapy: siRNA versus shRNA
by: Sebastian Aguiar, et al.
Published: (2017-11-01)

ShRNA-targeted centromere protein A inhibits hepatocellular carcinoma growth.
by: Yongmei Li, et al.
Published: (2011-01-01)

A random shRNA-encoding library for phenotypic selection and hit-optimization.
by: Yongping Wang, et al.
Published: (2008-09-01)

Correction: ShRNA-Targeted COMMD7 Suppresses Hepatocellular Carcinoma Growth.
by: Lu Zheng, et al.
Published: (2019-01-01)

Synthetic Pre-miRNA-Based shRNA as Potent RNAi Triggers
by: Kazuya Terasawa, et al.
Published: (2011-01-01)